FrancophonIA/ELRC3.0 huggingface dataset:
English: Other negative prognostic factors (age > 40 years, male gender, bridging fibrosis) should be taken into account in order to extend therapy to 12 months.
Croatian: Kod odluke o produljenju liječenja na 12 mjeseci moraju se uzeti u obzir drugi negativni prognostički faktori (dob iznad 40 godina, muški spol, premoštavajuća fibroza).
English: Diagram C
Croatian: Dijagram C
English: IntronA is available in nine different pack sizes: - Pack of 1 vial
Croatian: IntronA je dostupan kao: - pakiranje sa 1 bočicom.
English: Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving IntronA and ribavirin combination therapy.
Croatian: Poremećaji zuba i desni, koji mogu dovesti do gubitka zuba, prijavljeni su u bolesnika koji su primali kombiniranu terapiju lijekom IntronA i ribavirinom.
English: In addition, dry mouth could have a damaging effect on teeth and mucous membranes of the mouth during long-term treatment with the combination of IntronA and ribavirin.
Croatian: I suhoća usta može imati štetan učinak na zube i sluznicu usta tijekom dugotrajnog liječenja kombinacijom lijeka IntronA i ribavirina.
English: Any thyroid abnormality detected at that time must be treated with conventional therapy.
Croatian: Svaki utvrđeni poremećaj štitne žljezde mora se liječiti konvencionalnom terapijom.
English: Chronic myelogenous leukaemia The recommended dose of IntronA is 4 to 5 million IU/m2 administered daily subcutaneously.
Croatian: Kronična mijeloična leukemija Preporučena doza lijeka IntronA je 4 do 5 milijuna IU/m primijenjena supkutano svakoga dana.
English: Very rarely:
Croatian: vrlo rijetko:
English: - if you have thyroid disease that is not well controlled.
Croatian: - ako imate loše kontroliranu bolest štitnjače.
English: Patients were randomized to receive either pegylated interferon alfa-2b (1.5 µg/kg/week) plus ribavirin (800 mg/day) or IntronA (3 MIU TIW) plus ribavirin (800 mg/day) for 48 weeks with a follow-up period of 6 months.
Croatian: Bolesnici su bili randomizirani u skupine koje su primale pegilirani interferon alfa-2b (1,5 μg/kg na tjedan) i ribavirin (800 mg na dan) ili IntronA (3 milijuna IU triput na tjedan) i ribavirin (800 mg na dan) tijekom 48 tjedana, uz razdoblje praćenja od 6 mjeseci.
English: Hyperkinesia, tremor, dysphonia, paresthaesia, hypoaesthesia, hyperaesthesia, concentration impaired, somnolence
Croatian: glavobolja, omaglica hiperkinezija, tremor, disfonija, parestezija, hipoestezija, hiperestezija, poremećaj koncentracije, somnolencija
English: Infrequently, adult patients treated for chronic hepatitis C with IntronA developed thyroid abnormalities, either hypothyroidism or hyperthyroidism.
Croatian: U rijetkim su slučajevima odrasli bolesnici liječeni lijekom IntronA zbog kroničnog hepatitisa C razvili poremećaj rada štitne žljezde, bilo hipotireozu ili hipertireozu.
English: Thyroid supplemental monitoring specific for children and adolescents Approximately 12 % of children treated with interferon alfa-2b and ribavirin combination therapy developed increase in thyroid stimulating hormone (TSH).
Croatian: U približno 12% djece liječene kombiniranom terapijom interferonom alfa-2b i ribavirinom došlo je do povišenja vrijednosti hormona koji stimulira štitnu žljezdu (TSH).
English: These symptoms have been reported more frequently when shosaikoto, a Chinese herbal medicine, is administered concomitantly with interferon alpha (see section 4.5).
Croatian: Takvi su simptomi prijavljeni češće kada se istodobno s interferonom alfa uzimao shosaikoto, kineski biljni lijek (vidjeti dio 4.5).
English: Uncommonly reported side effects: bacterial infection, feeling of pins and needles, and pericarditis (inflammation of the lining of the heart).
Croatian: Manje često prijavljene nuspojave: bakterijska infekcija, osjećaj trnaca i bockanja i perikarditis (upala srčane ovojnice).
English: Patients were randomized to receive either pegylated interferon alfa-2b (100 or 150 µg /week based on weight) plus ribavirin (800-1,200 mg/day based on weight) or IntronA (3 MIU TIW) plus ribavirin (800-1,200 mg/day based on weight).
Croatian: Bolesnici su bili randomizirani tako da su primali pegilirani interferon alfa-2b (100 ili 150 μg na tjedan, ovisno o tjelesnoj težini) i ribavirin (800-1200 mg na dan, ovisno o tjelesnoj težini) ili IntronA (3 milijuna IU triput na tjedan) i ribavirin (800-1200 mg na dan, ovisno o tjelesnoj težini).
English: Current treatment guidelines should be consulted as to whether a liver biopsy is needed prior to commencing treatment.
Croatian: Treba proučiti važeće smjernice o liječenju kroničnog hepatitisa C kako bi se procijenila potreba za biopsijom jetre prije početka liječenja.
English: Epistaxis, respiratory disorder, nasal congestion, rhinorrhea, cough nonproductive Pulmonary infiltrates
Croatian: dispneja*, kašalj* epistaksa, respiratorni poremećaj, kongestija nosa, rinoreja, neproduktivan kašalj plućni infiltrati
English: th percentile).
Croatian: (potkožno).
English: Discontinue treatment with IntronA in patients with chronic hepatitis who develop prolongation of coagulation markers which might indicate liver decomposition.
Croatian: Liječenje lijekom IntronA treba prekinuti u bolesnika s kroničnim hepatitisom u kojih se produlji vrijeme zgrušavanja krvi jer to može ukazivati na dekompenzaciju jetre.
English: a: p value based on Cochran-Mantel Haenszel Chi square test. b: p value based on chi-square test. c: subjects < 75 kg received 100 µg/week pegylated interferon alfa-2b and subjects ≥ 75 kg received 150 µg/week pegylated interferon alfa-2b.
Croatian: mil.IU = milijun internacionalnih jedinica; a: p vrijednost dobivena Cochran-Mantel Haenszelovim hi-kvadrat testom; b: p vrijednost dobivena hi-kvadrat testom. c: ispitanici teški < 75 kg primali su 100 μg pegiliranog interferona alfa-2b na tjedan, a ispitanici teški ≥ 75 kg primali su 150 μg pegiliranog interferona alfa-2b na tjedan. d: doza ribavirina iznosila je 800 mg za bolesnike teške < 60 kg, 1000 mg za bolesnike teške 60-75 kg, te 1200 mg za bolesnike ≥ 75 kg.
English: - IntronA in combination with ribavirin
Croatian: - IntronA u kombinaciji s ribavirinom
English: IntronA should be given alone mainly in case of intolerance or contraindication to ribavirin.
Croatian: IntronA se treba primjenjivati samostalno uglavnom u bolesnika koji ne podnose ribavirin ili im je on kontraindiciran.
English: 12 multiple dose vials
Croatian: 12 višedoznih bočica
English: How to store IntronA
Croatian: Kako čuvati IntronA
English: IntronA alone or in combination with ribavirin has been studied in 4 randomised Phase III clinical trials in 2,552 interferon-naïve patients with chronic hepatitis C. The trials compared the efficacy of IntronA used alone or in combination with ribavirin.
Croatian: IntronA kao monoterapija ili u kombinaciji s ribavirinom ispitivao se u 4 randomizirana klinička ispitivanja faze III sa 2552 bolesnika s kroničnim hepatitisom C koji prethodno nisu liječeni interferonom.
English: Overall, in both studies, patients who received IntronA plus ribavirin, were less likely to respond than patients who received pegylated interferon alfa-2b with ribavirin.
Croatian: Općenito su u oba ispitivanja bolesnici koji su primali IntronA i ribavirin imali manju vjerojatnost za postizanje odgovora od onih koji su primali pegilirani interferon alfa-2b i ribavarin.
English: IntronA is given in combination with ribavirin.
Croatian: IntronA se primjenjuje u kombinaciji s ribavirinom.
English: Metabolism and nutrition disorders Very common:
Croatian: Poremećaji metabolizma i prehrane vrlo često: često:
English: Hypothyroidism Hyperthyroidism
Croatian: hipotireoza hipertireoza
English: Myocardial infarction, cardiac ischaemia Congestive heart failure, pericardial effusion, arrhythmia
Croatian: palpitacije, tahikardija perikarditis kardiomiopatija infarkt miokarda, srčana ishemija kongestivno zatajenje srca, perikardijalni izljev, aritmija
English: Diagram B
Croatian: Dijagram B
English: Chronic hepatitis B: 5 to 10 million IU 3 times a week (every other day) injected subcutaneously (under the skin).
Croatian: Kronični hepatitis B: 5 do 10 milijuna IU, triput na tjedan (svaki drugi dan) supkutanom injekcijom (potkožno).
English: Anaemia, neutropaenia Thrombocytopaenia, lymphadenopathy
Croatian: anemija, neutropenija trombocitopenija, limfadenopatija
English: 2 multiple dose vials
Croatian: 2 višedozne bočice
English: Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper quadrant pain, dyspepsia, glossitis, gastroesophageal reflux, rectal disorder, gastrointestinal disorder, constipation, loose stools, toothache, tooth disorder
Croatian: dijarea, povraćanje, mučnina, bol u trbuhu ulceracija usne šupljine, ulcerativni stomatitis, stomatitis, bol u gornjem desnom kvadrantu, dispepsija, glositis, gastroezofagealni refluks, rektalni poremećaj, poremećaj probavnog sustava, konstipacija, mekana stolica, zubobolja, poremećaj zuba
English: The increased response rate to the combination of IntronA + ribavirin, compared with IntronA alone, is maintained across all subgroups.
Croatian: Povećana stopa terapijskog odgovora na kombinaciju lijeka IntronA i ribavirina u odnosu na stopu terapijskog odgovora na monoterapiju lijekom IntronA održan je u svim podskupinama ispitanika.
English: Endocrine disorders Very common:
Croatian: Endokrini poremećaji vrlo često: često:
English: The best way to use IntronA in this indication is in combination with ribavirin.
Croatian: U ovoj je indikaciji IntronA najbolje primjenjivati u kombinaciji s ribavirinom.
English: Warnings and precautions Talk to your doctor, pharmacist or nurse before using IntronA - if you are pregnant or planning to become pregnant (see section “Pregnancy and breast-feeding”).
Croatian: Upozorenja i mjere opreza Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego primijenite IntronA - ako ste trudni ili planirate trudnoću (vidjeti dio "Trudnoća i dojenje"). - ako se liječite od psihičke bolesti ili ste se u prošlosti liječili od bilo kojeg drugog neurološkog ili psihičkog poremećaja, uključujući depresiju (poput osjećaja tuge, malodušnosti) ili ponašanje koje upućuje na moguće samoubojstvo ili ubojstvo (vidjeti dio 4. "Moguće nuspojave").
English: Decreased serum estradiol and progesterone concentrations have been reported in women treated with human leukocyte interferon.
Croatian: U žena liječenih humanim leukocitnim interferonom prijavljene su niže koncentracije estradiola i progesterona u serumu.
English: In the presence of thyroid dysfunction, IntronA treatment may be continued if TSH levels can be maintained in the normal range by medication.
Croatian: U slučaju poremećaja rada štitne žljezde liječenje lijekom IntronA može se nastaviti samo ako se razina TSH-a može lijekovima održavati u granicama normale.
English: Each vial contains 10 million IU in 1 mL of solution.
Croatian: Jedna bočica sadrži 10 milijuna IU u 1 ml otopine.
English: Also see ribavirin SPC if IntronA is to be administered in combination with ribavirin in patients with chronic hepatitis C.
Croatian: Pročitajte i Sažetak opisa svojstava lijeka za ribavirin ako će se IntronA primjenjivati u kombinaciji s ribavirinom u bolesnika s kroničnim hepatitisom C.
English: Within its shelf-life, for the purpose of transport, the solution can be kept at or below 25ºC for a period up to seven days before use.
Croatian: Kako bi se olakšao transport, otopina se unutar roka valjanosti može prije primjene čuvati na temperaturi od ili ispod 25°C najdulje 7 dana.
English: Diagram D
Croatian: Dijagram D
English: 5 million IU/0.5 mL
Croatian: 5 milijuna IU/0,5 ml
English: As with all parenteral medicinal products, prior to administration inspect IntronA, solution for injection or infusion, visually for particulate matter and discolouration.
Croatian: Kao i kod drugih lijekova za parenteralnu primjenu, prije primjene se mora provjeriti izgled IntronA otopine za injekciju ili infuziju, zbog moguće pojave vidljivih čestica ili promjene boje.
English: Do not use if discolouration or particulate matter is present.
Croatian: Ne smijete je upotrijebiti ako je promijenila boju ili su prisutne čestice.
English: Enuresis, micturition disorder, urinary incontinence
Croatian: enureza, poremećaj mokrenja, inkontinencija mokraće
English: Children and adolescents - Existence of, or history of severe psychiatric condition, particularly severe depression, suicidal ideation or suicide attempt.
Croatian: - Postojeća teška psihijatrijska bolest ili anamneza takve bolesti, osobito teška depresija, misli o samoubojstvu ili pokušaj samoubojstva.
English: If treatment with alpha interferon is judged necessary in these patients, the presence of psychiatric co-morbidities and the potential for other substance use should be carefully assessed and adequately managed before initiating therapy.
Croatian: Ako se procijeni da je liječenje interferonom alfa u takvih bolesnika neophodno, prije započinjanja liječenja treba pažljivo provjeriti postoje li popratne psihijatrijske bolesti ili rizik od uživanja sredstava ovisnosti te ih na odgovarajući način zbrinuti.
English: Check with your doctor immediately if any of the following side effects occur: - chest pain or persistent and severe cough; irregular or rapid heartbeat; shortness of breath, confusion, difficulty remaining alert, numbness or tingling sensation or pain in hands or feet; seizure (convulsions); trouble sleeping, thinking or concentrating; altered mental state; suicidal thoughts, suicide attempt, changed behaviour or aggressive behaviour (sometimes directed against others), hallucinations; severe stomach pain; black or tar like stools; blood in stool or urine, severe nosebleed; waxy pallor, high sugar level in blood, fever or chills beginning after a few weeks of treatment, lower back or side pain, difficult urination, problems with your eyes or your eyesight or hearing, loss of hearing, severe or painful reddening or sores on your skin or mucous membrane.
Croatian: Ako nastupi neka od sljedećih nuspojava, odmah se javite svom liječniku: - bol u prsištu ili jak kašalj koji ne prestaje; nepravilni ili ubrzani otkucaji srca; nedostatak zraka, smetenost, poteškoće održavanja budnosti, utrnulost ili trnci ili bol u šakama ili stopalima; napadaj (konvulzije); poteškoće sa spavanjem, razmišljanjem ili koncentracijom; promjena psihičkog stanja; razmišljanje o samoubojstvu, pokušaj samoubojstva, promjene ponašanja ili agresivno ponašanje (ponekad usmjereno protiv drugih), halucinacije; jaka bol u trbuhu; crna ili katranasta stolica, krv u stolici ili mokraći, jako krvarenje iz nosa; bljedilo poput voska, visoka razina šećera u krvi, vrućica ili zimica koje počinju nakon nekoliko tjedana liječenja, bol u križima ili slabinama, poteškoće s mokrenjem, tegobe s očima, vidom ili sluhom, gubitak sluha, teško ili bolno crvenilo ili ranice na koži ili sluznici.
English: - The other ingredients are disodium phosphate anhydrous, sodium dihydrogen phosphate monohydrate, edetate disodium, sodium chloride, m-cresol, polysorbate 80 and water for injections.
Croatian: - Drugi sastojci su: natrijev hidrogenfosfat, bezvodni; natrijev dihidrogenfosfat hidrat; dinatrijev edetat; natrijev klorid; m-krezol; polisorbat 80 i voda za injekcije.
English: SVR after treatment of chronic HCV with non-pegylated interferon alfa-2b (with or without ribavirin) results in long-term clearance of the virus providing resolution of the hepatic infection and clinical 'cure' from chronic HCV.
Croatian: Trajan virološki odgovor nakon liječenja kroničnog hepatitisa C nepegiliranim interferonom alfa-2b (sa ili bez ribavirina) rezultira dugotrajnom eliminacijom virusa, što omogućuje izlječenje infekcije jetre i kliničko „ozdravljenje“ od kroničnog hepatitisa C.
English: The development of auto-antibodies and autoimmune disorders has been reported during treatment with alpha interferons.
Croatian: Tijekom liječenja interferonima alfa prijavljen je razvoj autoantitijela i autoimunih poremećaja.
English: Children 3 years of age and older and adolescents - 3 million IU/m2 3 times a week (every other day) injected subcutaneously (under the skin) in combination with ribavirin (Please also see ribavirin package leaflet).
Croatian: Djeca u dobi od 3 i više godina i adolescenti3 milijuna IU/m2, triput na tjedan (svaki drugi dan) supkutanom injekcijom (potkožno), u kombinaciji s ribavirinom (pročitati i uputu o lijeku za ribavirin).
English: Co-administration of IntronA with ribavirin increased the efficacy of IntronA by at least two fold for the treatment of chronic hepatitis C in naïve patients.
Croatian: Primjena lijeka IntronA zajedno s ribavirinom povećala je najmanje dvostruko djelotvornost lijeka IntronA u liječenju kroničnog hepatitisa C u bolesnika koji prethodno nisu bili liječeni.
English: Response rates in these trials were increased with compliance.
Croatian: Stopa odgovora u ovim je ispitivanjima bila veća što je bila bolja suradljivost bolesnika.
English: See section 4.4 Class label for interferon products, see below Pulmonary arterial hypertension.
Croatian: * Ove su nuspojave bile česte samo u monoterapiji lijekom IntronA Vidjeti dio 4.4 Značajka skupine lijekova koji sadrže interferon, vidjeti niže Plućna arterijska hipertenzija
English: HOW TO SELF INJECT INTRONA Syringe with an unattached needle
Croatian: KAKO DA SI SAMI DATE INJEKCIJU LIJEKA INTRONA Štrcaljka s nepričvršćenom iglom
English: If thyroid abnormalities are detected, the patient's thyroid status should be evaluated and treated as clinically appropriate.
Croatian: U slučaju poremećaja rada štitne žljezde potrebno je procijeniti status štitne žljezde u bolesnika i liječiti ga sukladno kliničkom stanju.
English: Any unused medicine must be discarded after withdrawal of the dose.
Croatian: Nakon izvlačenja doze neiskorišten lijek se mora baciti.
English: Dyspnoea, tachypnea, epistaxis, coughing, nasal congestion, nasal irritation, rhinorrhea, sneezing
Croatian: dispneja, tahipneja, epistaksa, kašalj, kongestija nosa, iritacija nosne sluznice, rinoreja, kihanje
English: IntronA is administered subcutaneously at a dose of 3 million IU three times a week (every other day) to adult patients, whether administered as monotherapy or in combination with ribavirin.
Croatian: IntronA se odraslim bolesnicima daje supkutano u dozi od 3 milijuna IU triput na tjedan (svaki drugi dan), bilo da se primjenjuje kao monoterapija ili u kombinaciji s ribavirinom.
English: Commonly reported side effects: thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
Croatian: Često prijavljene nuspojave: žeđ, dehidracija, visok krvni tlak, migrene, natečene žlijezde, crvenilo praćeno osjećajem užarenosti, menstrualni problemi, smanjen spolni nagon, vaginalni problemi, bol u dojkama, bol u testisima, tegobe sa štitnjačom, crvenilo desni, suhoća usta, crvenilo ili bolnost usta ili jezika, zubobolja ili poremećaj zuba, herpes simplex (groznica), promjena osjeta okusa, želučane tegobe, loša probava (žgaravica), zatvor, povećanje jetre (tegobe s jetrom, ponekad teške), mekana stolica, mokrenje u krevet kod djece, upala sinusa, bronhitis, bol u oku, poremećaj suznih kanala, konjunktivitis ("crvene oči"), uznemirenost, pospanost, mjesečarenje, problemi u ponašanju, nervoza, začepljen nos ili curenje iz nosa, kihanje, ubrzano disanje, blijeda ili crvena koža, modrice, problemi s kožom ili noktima, psorijaza (novonastala ili pogoršana), pojačano znojenje, pojačana potreba za mokrenjem, fini drhtavi pokreti, smanjen osjet dodira, artritis.
English: Clean the rubber stopper on the top of the vial containing the IntronA solution with a cleansing swab.
Croatian: Očistite gumeni čep na vrhu bočice s IntronA otopinom tupferom za čišćenje.
English: Children 3 years of age and older and adolescents IntronA is indicated, in a combination regimen with ribavirin, for the treatment of children 3 years of age and older and adolescents, who have chronic hepatitis C, not previously treated, without liver decompensation, and who are positive for HCV-RNA.
Croatian: IntronA je u kombinaciji s ribavirinom indiciran za liječenje djece u dobi od 3 i više godina te adolescentata koji imaju kronični hepatitis C, nisu prethodno liječeni, nemaju dekompenzaciju jetre i imaju pozitivan nalaz HCV-RNK.
English: If you are receiving HAART, the addition of IntronA and ribavirin may increase your risk of lactic acidosis and of liver failure.
Croatian: Ako se liječite vrlo djelotvornom antiretrovirusnom terapijom, dodatak lijeka IntronA i ribavirina može povećati rizik od razvoja laktacidoze i zatajenja jetre.
English: Micturition frequency Renal failure, renal insufficiency, nephrotic syndrome
Croatian: učestalo mokrenje zatajenje bubrega, bubrežna insuficijencija, nefrotski sindrom
English: Musculoskeletal and connective tissue disorders Very common:
Croatian: Poremećaji mišićno-koštanog sustava i vezivnog tkiva vrlo često:
English: As induction therapy, interferon alfa-2b is administered intravenously at a dose of 20 million IU/m daily for five days a week for a four-week period; the calculated interferon alfa-2b dose is added to sodium chloride 9 mg/mL (0.9 %) solution for injection and administered as a 20-minute infusion (see section 6.6).
Croatian: Izračunata doza interferona alfa-2b dodaje se u otopinu natrijevog klorida za injekciju od 9 mg/ml (0,9%) i primjenjuje u obliku 20-minutne infuzije (vidjeti dio 6.6).
English: Adjunctively with chemotherapy, interferon alfa-2b may be administered subcutaneously, at a dose of 5 million IU three times a week (every other day) for a duration of 18 months.
Croatian: Interferon alfa-2b može se primjenjivati potkožno u dozi od 5 milijuna IU triput na tjedan (svaki drugi dan) tijekom 18 mjeseci kao adjuvantna terapija uz kemoterapiju.
English: IntronA 18 million IU/3 mL solution for injection or infusion
Croatian: IntronA 18 milijuna IU/3 ml otopina za injekciju ili infuziju
English: Not done
Croatian: Nije određen
English: Very commonly reported side effects: pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, stomach or abdominal pains, diarrhoea, nausea (feeling sick), viral infection, depression, emotional lability, insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count.
Croatian: Vrlo često prijavljene nuspojave: bol, oticanje i crvenilo ili oštećenje kože na mjestu injekcije, opadanje kose, omaglica, promjene teka, bol u želucu ili trbuhu, proljev, mučnina, virusna infekcija, depresija, emocionalna labilnost, nesanica, tjeskoba, grlobolja i bol pri gutanju, umor, zimica/tresavica, vrućica, reakcija nalik gripi, opće loše osjećanje, glavobolje, gubitak tjelesne težine, povraćanje, razdražljivost, slabost, promjene raspoloženja, kašalj (ponekad jak), nedostatak zraka, svrbež, suha koža, osip, iznenadna i jaka bol u mišićima, bol u zglobovima, mišićno-koštana bol, promjene u laboratorijskim nalazima krvi, uključujući smanjen broj bijelih krvnih stanica.
English: HCV/HIV Coinfection
Croatian: Istodobna infekcija HCV-om i HIV-om